To investigate the neuroanatomical driver of obesity-induced hypertension, an in...
✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.
To investigate the neuroanatomical driver of obesity-induced hypertension, an investigator microinjects a specific leptin receptor antagonist directly into the dorsomedial hypothalamus (DMH) of diet-induced obese (DIO) hypertensive mice. What is the expected physiological outcome?